Researchers working on the COVID vaccine that people can drink, Health News, ET HealthWorld

San Francisco: Researchers are working on a COVID-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as “swish and swallow” oral vaccines. The vaccine, called QYNDR, completed its phase 1 clinical trial and is currently waiting on more funding to conduct the more detailed, advanced trials that could actually bring the vaccine to market, reports CNET. “The QYNDR vaccine is pronounced ‘kinder’, because it’s a softer way to deliver a vaccine,” Kyle Flanigan, founder of…

Read More

INCOVACC: First made-in-India intranasal COVID vaccine to be launched on Republic Day, Health News, ET HealthWorld

Bhopal: Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC on January 26, the company’s CMD Krishna Ella announced on Saturday. The vaccine manufacturer had already received approval from the Central Drugs Standard Control Organisation (CDSCO) earlier this month for the nasal vaccine, the first of its kind in India. “Our nasal vaccine will be officially launched on Republic Day on January 26,” said Ella while participating in a session during the 8th edition of the India International Science Festival (IISF) that began at the Maulana Azad National Institute of…

Read More

SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults, Health News, ET HealthWorld

New Delhi: Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday. The letter was written by Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), they said. National Technical Advisory Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter. The Drug Controller General of India (DCGI) on January 16 approved market authorisation…

Read More

Govt panel recommends market authorisation for Covovax jab as heterologous booster dose, Health News, ET HealthWorld

New Delhi: An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India‘s Covid vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs Controller General of India (DCGI) for approval of Covovax heterologous booster dose for those aged 18 years and above in view of escalating COVID-19…

Read More

Moderna considers pricing COVID vaccine at $110-$130, Health News, ET HealthWorld

Cambridge: Moderna Inc is considering pricing its COVID-19 shot at $110 to $130 per dose in the United States when it shifts from government contracting to commercial distribution of the shots, the company’s Chief Executive Officer Stephane Bancel told the Wall Street Journal on Monday. “I would think this type of pricing is consistent with the value,” said Bancel, according to the WSJ report, adding the company was in discussions with hospital systems, pharmacies and pharmacy-benefit managers to line up distribution of its vaccine ahead of a potential fall booster…

Read More

Messenger RNA COVID-19 Vaccine: Researcher claims mRNA COVID-19 vaccines can increase serious adverse events; calls for it to be withdrawn from the market, Health News, ET HealthWorld

New Delhi: Joseph Fraiman, an emergency physician and a clinical scientist from Louisiana, claims that the messenger RNA COVID-19 vaccine can increase serious adverse events in people, including sudden cardiac deaths. In a video that surfaced online, Fraiman, who was a lead author of the peer reviewed research that re-analysed Pfizer & Moderna trials for mRNA COVID-19 vaccine, says, “We found the vaccine increases serious adverse events at a rate of one in 800. At the time of the publication, my co-authors and I did not believe our single study…

Read More

Coronavirus Infections: India reports 163 new Covid-19 cases; active cases dip to 2,423, Health News, ET HealthWorld

New delhi: India logged 163 new coronavirus infections, while the active cases declined to 2,423, according to the Union Health Ministry data updated on Sunday. The Covid case tally was recorded at 4.46 crore (4,46,79,924). The death toll stands at 5,30,720 with two deaths reconciled by Kerala, the data updated at 8 am stated. The active cases comprise 0.01 per cent of the total infections, while the national COVID-19 recovery rate has increased to 98.80 per cent, the ministry said. A decrease of 86 cases has been recorded in the…

Read More

India reports 188 new COVID cases in last 24 hours, Health News, ET HealthWorld

New Delhi: India recorded 188 new coronavirus infections in the last 24 hours, bringing the active COVID caseload to 3,468, as reported by the government of India. The current active caseload stands at 0.01 per cent. The daily COVID positivity rate stands at 0.14 per cent, whereas the weekly positivity rate stands at 0.18 per cent. The government relayed that the total recovery from coronavirus infections in the last 24 hours is recorded to be 141, bringing the total recovery tally to 4,41,43,483 since the onset of the pandemic, and…

Read More

Sudden COVID-19 outbreaks depict lack of efficacy of Chinese vaccines: Report, Health News, ET HealthWorld

Beijing: China’s sudden COVID-19 outbreaks “demonstrate a lack of effectiveness of its vaccines”, prompting global concerns, particularly in nations where Beijing’s vaccines have been accepted, Tibet Press reported. Turkish government which initially accepted Chinese vaccines is now scrutinising its efficacy after learning of China’s involvement in data tempering of side effects only to enhance its vaccine sale, as per the news report. In December 2020, Indonesia and Brazil initially reported 97 per cent and 78 per cent efficacy in Chinese vaccines. In 2021, Indonesia and Brazil reduced the efficacy to…

Read More

India reports 157 new COVID cases in last 24 hours, Health News, ET HealthWorld

New Delhi: India recorded 157 new coronavirus infections in the last 24 hours, bringing the active COVID caseload to 3,421, as reported by the government of India. The current active caseload stands at 0.01 per cent. The daily COVID positivity rate stands at 0.32 per cent, whereas the weekly positivity rate stands at 0.18 per cent. The government relayed that the total recovery from coronavirus infections in the last 24 hours is recorded to be 163, bringing the total recovery tally to 4,41,43,342 since the onset of the pandemic, and…

Read More